Tom will showcase several case studies, which will give our attendees real world examples to apply in their own business functions.
Philadelphia, PA (PRWEB) September 09, 2014
As part of its continued service to the industry, Pharmica Consulting will host its CRO Management and Partnership Conference on November 18 in Philadelphia, Pa. The conference will focus on how sponsors and CROs are managing their partnerships, in addition to the ways they are leveraging technology to increase efficiencies.
“Tom’s session will cover the impact of strategic partnerships on initial project planning, vision, and methodology. It will be enlightening for our audience to hear the ways in which a strategic partnership changes how sponsors are approaching oversight,” said Eric Lake, Partner at Pharmica Consulting.
“Tom will showcase several case studies, which will give our attendees real world examples to apply in their own business functions,” said Matt Hendricks, Partner at Pharmica Consulting.
“Many companies enter into a strategic partnership with a vision of how it will work on a day-to-day level, but that vision often changes over time. Tom will highlight the ways in which his partnerships have evolved, and what triggered those changes,” said Greg Cohee, Partner at Pharmica Consulting.
Those interested in learning more about Pharmica Consulting and upcoming events or service offerings can visit http://www.pharmicaconsulting.com/services/.To request additional information, please contact Chrissy Lione at 484-432-1658.
About Pharmica Consulting:
Pharmica Consulting, one of the life sciences industry’s leading consulting firms, provides a variety of offerings designed to help pharmaceutical and biotech clients achieve true operational excellence. Consultants at Pharmica invest the time needed to truly understand a client’s specific challenges and tailor solutions to help them create a more profitable business environment. Pharmica Consulting knows how to build effective strategies - and deliver against those strategies as promised.